Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes - PubMed (original) (raw)
Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes
R Bucala et al. J Clin Invest. 1991 Feb.
Abstract
Nitric oxide (an endothelium-derived relaxing factor) induces smooth muscle relaxation and is an important mediator in the regulation of vascular tone. Advanced glycosylation end products, the glucose-derived moieties that form nonenzymatically and accumulate on long-lived tissue proteins, have been implicated in many of the complications of diabetes and normal aging. We demonstrate that advanced glycosylation products quench nitric oxide activity in vitro and in vivo. Acceleration of the advanced glycosylation process in vivo results in a time-dependent impairment in endothelium-dependent relaxation. Inhibition of advanced glycosylation with aminoguanidine prevents nitric oxide quenching, and ameliorates the vasodilatory impairment. These results implicate advanced glycosylation products as important modulators of nitric oxide activity and endothelium-dependent relaxation.
Similar articles
- Advanced glycation end products quench nitric oxide in vitro.
Uhlmann S, Rezzoug K, Friedrichs U, Hoffmann S, Wiedemann P. Uhlmann S, et al. Graefes Arch Clin Exp Ophthalmol. 2002 Oct;240(10):860-6. doi: 10.1007/s00417-002-0548-x. Epub 2002 Sep 25. Graefes Arch Clin Exp Ophthalmol. 2002. PMID: 12397436 - Na+/H+ exchanger is required for hyperglycaemia-induced endothelial dysfunction via calcium-dependent calpain.
Wang S, Peng Q, Zhang J, Liu L. Wang S, et al. Cardiovasc Res. 2008 Nov 1;80(2):255-62. doi: 10.1093/cvr/cvn179. Epub 2008 Jun 30. Cardiovasc Res. 2008. PMID: 18591204 - Nitric oxide and vascular responses in Type I diabetes.
Chan NN, Vallance P, Colhoun HM. Chan NN, et al. Diabetologia. 2000 Feb;43(2):137-47. doi: 10.1007/s001250050022. Diabetologia. 2000. PMID: 10753034 Review.
Cited by
- Roseburia intestinalis: A possible target for vascular calcification.
Pan X, Song Y, Liang Y, Feng G, Wang Z. Pan X, et al. Heliyon. 2024 Oct 26;10(21):e39865. doi: 10.1016/j.heliyon.2024.e39865. eCollection 2024 Nov 15. Heliyon. 2024. PMID: 39524709 Free PMC article. Review. - Diabetes-Related Changes in Carotid Wall Properties: Role of Triglycerides.
Kozakova M, Morizzo C, Penno G, Chiappino D, Palombo C. Kozakova M, et al. J Clin Med. 2024 Sep 23;13(18):5654. doi: 10.3390/jcm13185654. J Clin Med. 2024. PMID: 39337141 Free PMC article. - The role of nonmyocardial cells in the development of diabetic cardiomyopathy and the protective effects of FGF21: a current understanding.
Zhang T, Jiang D, Zhang X, Chen L, Jiang J, Zhang C, Li S, Li Q. Zhang T, et al. Cell Commun Signal. 2024 Sep 26;22(1):446. doi: 10.1186/s12964-024-01842-0. Cell Commun Signal. 2024. PMID: 39327594 Free PMC article. Review. - Association between endothelial function and skin advanced glycation end-products (AGEs) accumulation in a sample of predominantly young and healthy adults.
Fewkes JJ, Dordevic AL, Murray M, Williamson G, Kellow NJ. Fewkes JJ, et al. Cardiovasc Diabetol. 2024 Sep 9;23(1):332. doi: 10.1186/s12933-024-02428-3. Cardiovasc Diabetol. 2024. PMID: 39251982 Free PMC article. - Acute Hyperglycemia-Induced Injury in Myocardial Infarction.
Pepe M, Addabbo F, Cecere A, Tritto R, Napoli G, Nestola PL, Cirillo P, Biondi-Zoccai G, Giordano S, Ciccone MM. Pepe M, et al. Int J Mol Sci. 2024 Aug 4;25(15):8504. doi: 10.3390/ijms25158504. Int J Mol Sci. 2024. PMID: 39126075 Free PMC article. Review.
References
- Arch Biochem Biophys. 1972 Jul;151(1):137-41 - PubMed
- J Pharm Sci. 1963 Jul;52:637-9 - PubMed
- J Clin Invest. 1980 Nov;66(5):1179-81 - PubMed
- Science. 1981 Jan 30;211(4481):491-3 - PubMed
- Diabetes. 1982 Dec;31(12):1123-7 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources